Latest Breaking News On - Vera therapeutics company profile - Page 1 : vimarsana.com

Vera Therapeutics, Inc (NASDAQ:VERA) Given Consensus Recommendation of Buy by Brokerages

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The […]

United statesRaymond jamesJosephr youngVera therapeutics company profileVera therapeutics incVirtu financialFirst light asset managementArtal groupVera therapeuticsGet free reportState teachers retirement systemCapital managementTherapeutics stock downGet freeVera therapeutics daily

New York State Common Retirement Fund Increases Stock Position in Vera Therapeutics, Inc (NASDAQ:VERA)

New York State Common Retirement Fund increased its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 55.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,491 shares of the company’s stock after buying an additional 6,244 shares during the period. New York State Common Retirement Fund’s holdings in Vera […]

New yorkUnited statesRaymond jamesMaha katabiJosephr youngZurcher kantonalbank zurich cantonalbankBarclays plcSwiss national bankVera therapeutics incYork state common retirement fundVera therapeutics company profileMirae asset global investments coSecurities exchange commissionNew york state common retirement fundVera therapeuticsFree report

Vera Therapeutics (NASDAQ:VERA) PT Raised to $68 00

Vera Therapeutics (NASDAQ:VERA) PT Raised to $68 00
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Josephr youngRaymond jamesRaymond jameSecurities exchange commissionSchroder investment management groupLord abbettRafferty asset managementVera therapeutics incVanguard group incVera therapeutics company profileVera therapeuticsGet free reportExchange commissionInvestment management groupCapital managementAsset management

Vera Therapeutics (NASDAQ:VERA) Given New $68 00 Price Target at Raymond James

Vera Therapeutics (NASDAQ:VERA) Given New $68 00 Price Target at Raymond James
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Zurcher kantonalbank zurich cantonalbankRaymond jamesRaymond jameMaha katabiChina universal asset management coVera therapeutics incVera therapeutics company profileCapstone investment advisorsSg americas securitiesSecurities exchange commissionVera therapeuticsGet free reportTherapeutics trading downExchange commissionDirector maha katabiUniversal asset management

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results

Vera Therapeutics (NASDAQ:VERA) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Josephr youngRaymond jamesMaha katabiVera therapeutics company profileVera therapeutics incVera therapeuticsGet free reportTherapeutics stock downDirector maha katabiVera therapeutics daily